Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-10-30
DOI: 10.1111/apt.71081 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-10-30. Written by Sara Cmet and 4 co-authors. Institution: Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Udine, Italy. 5 references.
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Udine, Italy.
- Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- CRC 'A. M. And A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
ORCID profiles: Elisabetta Degasperi, Pietro Lampertico, Pierluigi Toniutto
Cite
APA
Cmet, S., Falleti, E., Degasperi, E., Lampertico, P., & Toniutto, P. (2026). Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71081
Vancouver
Cmet S, Falleti E, Degasperi E, Lampertico P, Toniutto P. Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71081
BibTeX
@article{Cmet2026,
author = {Cmet, Sara and Falleti, Edmondo and Degasperi, Elisabetta and Lampertico, Pietro and Toniutto, Pierluigi},
title = {Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71081}
}
EUVIMED